Status:
COMPLETED
Selective Retina Therapy (SRT) for Clinically Significant Diabetic Macular Edema
Lead Sponsor:
University Hospital Schleswig-Holstein
Collaborating Sponsors:
Medical Laser Center Lübeck, Germany
St Thomas
Conditions:
Diabetic Macular Edema
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Selective Retina Therapy (SRT) is an effective and safe laser treatment of clinically significant diabetic macular edema which targets the retinal pigment epithelium while sparing the neurosensory ret...
Detailed Description
Abstract: OBJECTIVE: To evaluate effectivity and safety of Selective Retina Therapy (SRT) for diabetic macular edema (DME). DESIGN: Prospective two-center interventional uncontrolled case series. PA...
Eligibility Criteria
Inclusion
- Minimum age of 18 years and the presence of clinically significant DME according to the criteria of the ETDRS study
Exclusion
- Ischemic diabetic macular edema, significant media opacity compromising the interpretation of fluorescein angiography and fundus photography, previous intraocular surgery, previous macular laser treatment, other retinal or ocular diseases, and known allergic hypersensitivity to fluorescein, indocyanine green, or iodine. General exclusion criteria included pregnancy or breast-feeding and significant medical conditions such as renal failure.
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT00994955
Start Date
January 1 2006
End Date
October 1 2009
Last Update
January 16 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.